ArticleJournal of Alzheimer's disease reports

Long-term safety and tolerability of brexpiprazole for Japanese patients with agitation in Alzheimer's disease dementia: A multicenter, open-label study.

Yu Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.